AACR 2019 Combo of virotherapy and radiotherapy shows early promise in patients with oesophageal cancer

AACR 2019: Combo of virotherapy and radiotherapy shows early promise in patients with oesophageal cancer

10:43 EDT 3 Apr 2019 | ecancermedicalscience

he experimental oncolytic adenovirus telomelysin (OBP-301) in combination with radiotherapy was safe and showed early clinical efficacy in vulnerable patients with oesophageal cancer, according to results from a phase I clinical trial presented at the...

More From BioPortfolio on "AACR 2019: Combo of virotherapy and radiotherapy shows early promise in patients with oesophageal cancer"